These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 10421707)

  • 1. GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans.
    Villemagne VL; Wong DF; Yokoi F; Stephane M; Rice KC; Matecka D; Clough DJ; Dannals RF; Rothman RB
    Synapse; 1999 Sep; 33(4):268-73. PubMed ID: 10421707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.
    Villemagne VL; Rothman RB; Yokoi F; Rice KC; Matecka D; Dannals RF; Wong DF
    Synapse; 1999 Apr; 32(1):44-50. PubMed ID: 10188637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
    Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang DR; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann JJ; Foged C; Halldin C; Laruelle M
    Synapse; 1999 May; 32(2):93-109. PubMed ID: 10231129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR12909 decanoate.
    Baumann MH; Ayestas MA; Sharpe LG; Lewis DB; Rice KC; Rothman RB
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1190-7. PubMed ID: 12023554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat.
    Baumann MH; Char GU; De Costa BR; Rice KC; Rothman RB
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1216-22. PubMed ID: 7996429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion.
    Carson RE; Breier A; de Bartolomeis A; Saunders RC; Su TP; Schmall B; Der MG; Pickar D; Eckelman WC
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):437-47. PubMed ID: 9143226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum.
    Drevets WC; Price JC; Kupfer DJ; Kinahan PE; Lopresti B; Holt D; Mathis C
    Neuropsychopharmacology; 1999 Dec; 21(6):694-709. PubMed ID: 10633475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine-free amino acid mixture attenuates amphetamine-induced displacement of [11C]raclopride in striatum in vivo: a rat PET study.
    Le Masurier M; Houston G; Cowen P; Grasby P; Sharp T; Hume S
    Synapse; 2004 Feb; 51(2):151-7. PubMed ID: 14618682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat.
    Egerton A; Ahmad R; Hirani E; Grasby PM
    Psychopharmacology (Berl); 2008 Nov; 200(4):487-96. PubMed ID: 18597077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.
    Baumann MH; Phillips JM; Ayestas MA; Ali SF; Rice KC; Rothman RB
    Ann N Y Acad Sci; 2002 Jun; 965():92-108. PubMed ID: 12105088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.
    Martinez D; Slifstein M; Broft A; Mawlawi O; Hwang DR; Huang Y; Cooper T; Kegeles L; Zarahn E; Abi-Dargham A; Haber SN; Laruelle M
    J Cereb Blood Flow Metab; 2003 Mar; 23(3):285-300. PubMed ID: 12621304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
    Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride?: PET studies combined with microdialysis in conscious monkeys.
    Tsukada H; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Harada N
    Brain Res; 1999 Sep; 841(1-2):160-9. PubMed ID: 10546998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of amphetamine-induced striatal dopamine release and cortisol responses to psychological stress.
    Wand GS; Oswald LM; McCaul ME; Wong DF; Johnson E; Zhou Y; Kuwabara H; Kumar A
    Neuropsychopharmacology; 2007 Nov; 32(11):2310-20. PubMed ID: 17342167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic modeling of [11C]raclopride: combined PET-microdialysis studies.
    Endres CJ; Kolachana BS; Saunders RC; Su T; Weinberger D; Breier A; Eckelman WC; Carson RE
    J Cereb Blood Flow Metab; 1997 Sep; 17(9):932-42. PubMed ID: 9307606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response and duration effects of acute administrations of cocaine and GBR12909 on dopamine synthesis and transporter in the conscious monkey brain: PET studies combined with microdialysis.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Kakiuchi T
    Brain Res; 2000 Mar; 860(1-2):141-8. PubMed ID: 10727633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.
    Boileau I; Dagher A; Leyton M; Gunn RN; Baker GB; Diksic M; Benkelfat C
    Arch Gen Psychiatry; 2006 Dec; 63(12):1386-95. PubMed ID: 17146013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method.
    Breier A; Su TP; Saunders R; Carson RE; Kolachana BS; de Bartolomeis A; Weinberger DR; Weisenfeld N; Malhotra AK; Eckelman WC; Pickar D
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2569-74. PubMed ID: 9122236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.
    Felger JC; Mun J; Kimmel HL; Nye JA; Drake DF; Hernandez CR; Freeman AA; Rye DB; Goodman MM; Howell LL; Miller AH
    Neuropsychopharmacology; 2013 Oct; 38(11):2179-87. PubMed ID: 23657438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related changes in the striatal dopaminergic system in the living brain: a multiparametric PET study in conscious monkeys.
    Harada N; Nishiyama S; Satoh K; Fukumoto D; Kakiuchi T; Tsukada H
    Synapse; 2002 Jul; 45(1):38-45. PubMed ID: 12112412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.